Please assess the completion status of the following clinical trial:

Trial Title: Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Patients with relapsing/refractory T-NK/NK lymphoma:~* Ages 18 years and above~* Patients must have a diagnosis of NK-cell (or T-NK) non-Hodgkin's lymphoma, nasal or nasal-type.~* Stage I, II, III, or IV disease~* Creatinine less than 3 x upper limit of normal (ULN)~* Able to give informed consent~* No prior treatment with asparaginase~Patients with T-NK/NK lymphoma (de novo patients ):~* Ages 18 years and above~* Patients must have a diagnosis of NK-cell (or T-NK) non-Hodgkin's lymphoma, nasal or nasal-type.~* Stage I, II, III, or IV disease~* Creatinine less than 3 x upper limit of normal (ULN)~* Able to give informed consent~* no prior chemotherapy or radiotherapy~Exclusion Criteria:~* Patients who are pregnant or nursing~* Any factor which might limit the patient's ability to provide informed consent~* Liver insufficiency~* Evolutive thrombosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).